The Disease Activity Score and the EULAR response criteria

Clinical and Experimental Rheumatology

Volumn 23, Issue 5 SUPPL. 39, 2005, Pages

  Fransen, J ^a   Van Riel, P L C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinical assessment; Disease activity; Response; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; PLACEBO; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR ANTIBODY;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE ACTIVITY; HUMAN; JOINT SWELLING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT RESPONSE; ACUTE PHASE RESPONSE; CLINICAL TRIAL (TOPIC); DAS28; DISEASE ACTIVITY SCORE; DISEASE COURSE; DRUG RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; EUROPEAN LEAGUE AGAINST RHEUMATISM RESPONSE CRITERIA; GENERAL HEALTH STATUS ASSESSMENT; HEALTH ASSESSMENT QUESTIONNAIRE; INFLAMMATION; PAIN ASSESSMENT; PROGNOSTIC ASSESSMENT; REMISSION; REPRODUCIBILITY; VALIDATION PROCESS; VISUAL ANALOG SCALE; COMPARATIVE STUDY; HOSPITALIZATION; JOINT; MEDICAL SOCIETY; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RHEUMATOLOGY; TREATMENT OUTCOME;

ARTHRITIS, RHEUMATOID; HUMANS; JOINTS; PROGNOSIS; REMISSION INDUCTION; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 33644790320     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. VAN RIEL PLCM: Provisional guidelines for measuring disease activity in clinical trials on Rheumatoid Arthritis. Br J Rheumatol 1992; 31: 793-6.
2. FELSON DT, ANDERSON JJ, BOERS M et al.: The American College of Rheumatology preliminary core-set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993; 36: 729-40.
3. VAN DER HEIJDE DMFM, VAN'T HOF MA, VAN RIEL PLCM et al.: Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49: 916-20.
4. VAN DER HEIJDE DMFM, VAN'T HOF MA, VAN RIEL PLCM, VAN DE PUTTE LBA: Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 1993; 20: 579-81.
5. FELSON DT, ANDERSON JJ, BOERS M et al.: American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727-35.
6. VAN RIEL PLCM, VAN GESTEL AM, VAN DE PUTTE LBA: Development and validation of reponse criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. Br J Rheumatol 1996; 35 (Suppl. 2): 4-7.
7. VAN GESTEL AM, PREVOO MLL, VAN'T HOF MA, VAN RIJSWIJK MH, VAN DE PUTTE LBA, VAN RIEL PLCM: Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Arthritis Rheum 1996; 39: 34-40.
8. VAN GESTEL AM, HAAGSMA CJ, VAN RIEL PLCM: Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998; 41: 1845-50.
9. VAN GESTEL AM, ANDERSON JJ, VAN RIEL PLCM et al.: ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. J Rheumatol 1999; 26: 705-11.
10. BOERS M, TUGWELL P: The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials. J Rheumatol 1993; 20: 568-74.
11. FRANSEN J, STUCKI G, VAN RIEL PLCM: Rheumatoid arthritis measures. Arthritis Rheum 2003; 49 (Suppl. 5): S214-24.
12. PREVOO MLL, VAN GESTEL AM, VAN'T HOF MA, VAN RIJSWIJK MH, VAN DE PUTTE LBA, VAN RIEL PLCM: Remission in a prospective study of patients with rheumatoid arthritis. Br J Rheumatol 1996; 35: 1101-5.
13. VAN EDE AE, LAAN RF, ROOD MJ et al.: Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2001; 44: 1515-24.
14. PREVOO MLL, VAN'T HOF MA, KUPER HH, VAN LEEUWEN MA, VAN DE PUTTE LBA, VAN RIEL PLCM: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-48.
15. VAN DER HEIJDE DMFM, VAN'T HOF MA, VAN RIEL PLCM, VAN LEEUWEN MA, VAN RIJSWIJK MH, VAN DE PUTTE LBA: Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis 1992; 51: 177-81.
16. SALAFFI F, PERONI M, FERRACCIOLI GF: Discriminating ability of composite indices for measuring disease activity in rheumatoid arthritis: a comparison of the Chronic Arthritis Systemic Index, Disease Activity Score and Thompson's Articular Index. Rheumatology 2000;39:90-6.
17. VILLAVERDE V, BALSA A, CANTALEJO M et al.: Activity indices in rheumatoid arthritis. J Rheumatol 2000; 27: 2576-81.
18. DROSSAERS-BAKKER KW, DE BUCK M, VAN ZEBEN D, ZWINDEMAN AH, BREEDVELD FC, HAZES JMW: Long-term course and outcome of functional capacity in rheumatoid arthritis. Arthritis Rheum 1999; 42: 1854-860.
19. WELSING PMJ, VAN GESTEL AM, SWINKELS HL, KIEMENEY LALM, VAN RIEL PLCM: The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001; 44: 2009-17.
20. WELSING PMJ, LANDEWE, RB, VAN RIEL PLCM et al.: The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum 2004; 50: 2082-93.
21. FRANSEN J, CREEMERS MCW, VAN RIEL PLCM: Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology 2004; 43: 1252-5.
22. VAN RIEL PL, REEKERS P, VAN DE PUTTE LB, GRIBNAU FW: Association of HLA antigens, toxic reactions and therapeutic response to auranofin and aurothioglucose in patients with rheumatoid arthritis. Tissue Antigens 1983; 22: 194-9.
23. VERHOEVEN AC, BOERS M, VAN DER LINDEN S: Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis. Ann Rheum Dis 2000; 39: 966-74.
24. BOERS M: Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial. Arthritis Rheum 2001; 44: 2703-4.
25. WOLFE F, CUSH JJ, O'DELL JR et al.: Consensus recommendations for the assessment and treatment of rheumatoid arthritis. J Rheumatol 2001; 28: 1413-30.
26. FRANSEN J, STUCKI G, VAN RIEL PLCM: The merits of monitoring: should we follow all our rheumatoid arthritis patients in daily practice? Rheumatology (Oxford) 2002; 41: 601-4.
27. VAN RIEL PLCM, VAN GESTEL AM: Area under the curve for the American College of Rheumatology improvement criteria: a valid addition to existing criteria in rheumatoid arthritis? Arthritis Rheum 2001; 44: 1719-722.
28. DEN BROEDER AA, CREEMERS MCW, VAN GESTEL AM, VAN RIEL PLCM: Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-a. Rheumatology (Oxford) 2002; 41: 638-42.
29. GRIGOR C, CAPELL HA, STIRLING A et al.: Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004; 364: 263-9.
30. FRANSEN J, BERNELOT MOENS H, SPEYER I, VAN RIEL PLCM: The effectiveness of systematic monitoring of RA disease activity in daily practice (TRAC): A multi-centre, cluster-randomised controlled trial. Ann Rheum Dis 2005 (in press).
31. VAN DER HEIJDE DMFM, JACOBS JWG: The original DAS and the DAS28 are not interchangable: comment on the articles by Prevoo et al. Arthritis Rheum 1998; 41: 942-3.
32. VAN RIEL PLCM and VAN GESTEL AM. Reply. Arthritis Rheum 1998; 41: 943-5.
33. FRANSEN J, LANGENEGGER T, MICHEL BA, STUCKI G: Feasibility and validity of the RADAI, a self-administered Rheumatoid Arthritis Disease Activity Index. Rheumatology (Oxford) 2000; 39: 321-7.